Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Porter, David"'
Autor:
Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: Elise.Chong@pennmedicine.upenn.edu., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Therwhanger D; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Gerson JN; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Fraietta JA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Stefano N; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Garfall AL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jul; Vol. 30 (7), pp. 726.e1-726.e8. Date of Electronic Publication: 2024 Mar 16.
Autor:
Ghilardi G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Paruzzo L; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Patel V; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Svoboda J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chong ER; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Fardella E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chong EA; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Gabrielli G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Nasta SD; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Carter J; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Pajarillo R; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Barta SK; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., White G; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Weber E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Napier E; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Garfall AL; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Schuster SJ; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Ruella M; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.; Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.
Publikováno v:
Journal of hematology & oncology [J Hematol Oncol] 2024 Apr 22; Vol. 17 (1), pp. 19. Date of Electronic Publication: 2024 Apr 22.
Autor:
Andersen L; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA. Electronic address: lucander@upenn.edu., Baker KM; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA., Difilippo H; Cell Therapy and Transplant Program, Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA., Meghani SH; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA., Porter D; Cell Therapy and Transplant Program, Abramson Cancer Center at the University of Pennsylvania, and Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA., Deng J; Department of Biobehavioral Health Sciences, School of Nursing, The University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Seminars in oncology nursing [Semin Oncol Nurs] 2024 Apr; Vol. 40 (2), pp. 151614. Date of Electronic Publication: 2024 Mar 04.
Autor:
Ghilardi G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Williamson S; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Pajarillo R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Paruzzo L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chen L; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Grady C; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Doucette A; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia., Nemecek E; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Gabrielli G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Barta SK; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Svoboda J; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chong EA; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Yelton R; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Nasta SD; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Landsburg DJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ugwuanyi O; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Chen AI; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Schachter L; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., White G; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ballard HJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Weber E; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Curley C; Division of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia., Porter DL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia., Garfall AL; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Guerra CE; Division of General Medicine, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia., Maziarz RT; Adult Blood and Marrow Stem Cell Transplant and Cell Therapy Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Schuster SJ; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia., Ruella M; Division of Hematology and Oncology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia.; Center for Cellular Immunotherapies and Cellular Therapy and Transplant, University of Pennsylvania, Philadelphia.; Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Apr; Vol. 3 (4), pp. EVIDoa2300213. Date of Electronic Publication: 2024 Mar 26.
Autor:
Scordo M; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Flynn JR; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY., Gonen M; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY., Devlin SM; Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY., Parascondola A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tomas AA; Department of Hematology, Hospital Gregorio Marañón, Madrid, Spain., Shouval R; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY., Brower J; Cell Therapy and Transplant and Lymphoma Programs, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Porter DL; Cell Therapy and Transplant and Lymphoma Programs, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Schuster SJ; Cell Therapy and Transplant and Lymphoma Programs, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Bachanova V; Division of Hematology, Oncology and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Maakaron J; Division of Hematology, Oncology and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN., Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Chen AI; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR., Nastoupil LJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., McGuirk JP; Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS., Oluwole OO; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN., Ip A; Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ., Leslie LA; Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.; Department of Oncology, Hackensack Meridian School of Medicine, Nutley, NJ., Bishop MR; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Riedell PA; The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Perales MA; Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.
Publikováno v:
Blood advances [Blood Adv] 2023 Sep 26; Vol. 7 (18), pp. 5579-5585.
Autor:
Li Y; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Hwang WT; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Maude SL; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Teachey DT; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Frey NV; Division of Hematology Oncology, Abramson Cancer Center, Cell Therapy and Transplant, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Myers RM; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Barz Leahy A; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Liu H; Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Porter DL; Division of Hematology Oncology, Abramson Cancer Center, Cell Therapy and Transplant, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Grupp SA; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Shaw PA; Biostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, Washington.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Sep 15; Vol. 28 (18), pp. 3940-3949.
Autor:
Melenhorst JJ; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. mej@pennmedicine.upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA. mej@pennmedicine.upenn.edu., Chen GM; Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA, USA., Wang M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Porter DL; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chen C; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Collins MA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA, USA., Gao P; Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA., Bandyopadhyay S; Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA, USA., Sun H; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Zhao Z; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lundh S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Pruteanu-Malinici I; Novartis Institute for Biomedical Research, Cambridge, MA, USA., Nobles CL; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Maji S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Frey NV; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gill SI; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Loren AW; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tian L; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Kulikovskaya I; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Gupta M; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Ambrose DE; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Davis MM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fraietta JA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Brogdon JL; Novartis Institute for Biomedical Research, Cambridge, MA, USA., Young RM; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Chew A; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Siegel DL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Transfusion Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Alanio C; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Wherry EJ; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA.; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Bushman FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Lacey SF; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Tan K; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.; Graduate Group in Genomics and Computational Biology, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu.; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA. tank1@chop.edu.; Graduate Group in Cell & Molecular Biology, University of Pennsylvania, Philadelphia, PA, USA. tank1@chop.edu., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. cjune@upenn.edu.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, USA. cjune@upenn.edu.
Publikováno v:
Nature [Nature] 2022 Feb; Vol. 602 (7897), pp. 503-509. Date of Electronic Publication: 2022 Feb 02.
Autor:
Kong W; Department of Microbiology.; Center for Cellular Immunotherapies.; Abramson Cancer Center, and., Dimitri A; Department of Microbiology.; Center for Cellular Immunotherapies.; Abramson Cancer Center, and., Wang W; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Jung IY; Department of Microbiology.; Center for Cellular Immunotherapies.; Abramson Cancer Center, and., Ott CJ; Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts, USA., Fasolino M; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Wang Y; Center for Cellular Immunotherapies., Kulikovskaya I; Center for Cellular Immunotherapies., Gupta M; Center for Cellular Immunotherapies., Yoder T; Center for Cellular Immunotherapies., DeNizio JE; Department of Medicine and.; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Everett JK; Department of Microbiology., Williams EF; Department of Microbiology.; Center for Cellular Immunotherapies.; Abramson Cancer Center, and., Xu J; Center for Cellular Immunotherapies., Scholler J; Center for Cellular Immunotherapies., Reich TJ; Center for Cellular Immunotherapies., Bhoj VG; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Haines KM; Center for Cellular Immunotherapies., Maus MV; Department of Medicine, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts, USA., Melenhorst JJ; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Young RM; Center for Cellular Immunotherapies., Jadlowsky JK; Center for Cellular Immunotherapies., Marcucci KT; Center for Cellular Immunotherapies., Bradner JE; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA., Levine BL; Center for Cellular Immunotherapies.; Abramson Cancer Center, and.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Porter DL; Abramson Cancer Center, and.; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Bushman FD; Department of Microbiology., Kohli RM; Department of Medicine and.; Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania, USA., June CH; Center for Cellular Immunotherapies.; Abramson Cancer Center, and.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Davis MM; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Lacey SF; Center for Cellular Immunotherapies.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Vahedi G; Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fraietta JA; Department of Microbiology.; Center for Cellular Immunotherapies.; Abramson Cancer Center, and.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Publikováno v:
The Journal of clinical investigation [J Clin Invest] 2021 Aug 16; Vol. 131 (16).
Autor:
Chong EA; Lymphoma Program and Cell Therapy and Transplant Program, Hematology-Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., Porter DL; Lymphoma Program and Cell Therapy and Transplant Program, Hematology-Oncology Division, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.
Publikováno v:
Hematology. American Society of Hematology. Education Program [Hematology Am Soc Hematol Educ Program] 2020 Dec 04; Vol. 2020 (1), pp. 590-597.
Autor:
Freyer CW; Department of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, Pa. Electronic address: Craig.Freyer@pennmedicine.upenn.edu., Porter DL; Division of Cellular Therapy and Stem Cell Transplant, Hospital of the University of Pennsylvania, Philadelphia, Pa; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2020 Nov; Vol. 146 (5), pp. 940-948. Date of Electronic Publication: 2020 Aug 06.